In previous work in EwS, we found that tumor xenografts in response to adoptive therapy with GD2-redirected CAR NK cells or CART strongly upregulate the nonclassical MHC class I molecule HLA-G [6,26]. The gene discussed is HLA-G; the disease is neoplasm.